Isentress pricing: community sign-on letter The Fair Pricing Coalition is asking Merck to price its new and very important integrase inhibitor at a level everyone can live with. The letter is seeking organization and individual signers until the official launch of the drug, when the price will be announced. “A new HIV drug produced by […]
Category: AIDS Treatment News
Barcelona International Conference, July 7-12 Web sites to watch John S. James The XIV International AIDS Conference will take place July 7-12 in Barcelona, Spain — with important satellite meetings starting several days before. These meetings happen only once every two years; no breakthroughs are expected, but important research and medical developments will be […]
Homocysteine, HIV, and Heart Disease Jennifer E. Cohn [Note: Abnormally high levels of homocysteine in the blood are associated with increased risk of heart disease, and a number of other diseases as well. These high levels can be detected by a blood test, and are often caused by dietary deficiencies that can be corrected. [Reducing […]
WTO accepts rules limiting medicine exports to poor countries – World Trade Organization John S. James On August 30, 2003, a World Trade Organization (WTO) meeting in Geneva, Switzerland adopted new rules on exporting generic copies of patented drugs to poor countries. The WTO and some of its trade delegates presented these rules as a […]
New HIV treatment guidelines give more advice – Brief Article John S. James New HIV treatment guidelines for adults and adolescents, developed by a panel of experts convened by the U.S. Department of Human Services, were published July 14, 2003. This standard differs from previous editions in giving more direction to physicians, especially in choosing […]
HIV treatment and immunology research: current ideas John S. James A recent report on two specialized scientific conferences looks at some of the most important current ideas on developing new kinds of HIV treatments. The conferences took place in April 2004, and the report (1), by immunologist Gareth Hardy, PhD, was published in July. 1 […]
Updated Guidelines for Prevention of Mother-to-Infant Transmission – of HIV infection On May 4 the U.S. Public Health Service released an updated version of the official guidelines for use of antiretrovirals to reduce perinatal HIV transmission. The following sections have been changed: * “Antiretroviral Clinical Scenarios” (beginning on page 17); * “Recommendations for Monitoring of […]
FDA approves once-daily efavirenz formulation, revised labeling The FDA sent the following email on February 4: The FDA approved on February 1, 2002, a new formulation of Sustiva (efavirenz), a non nucleoside reverse transcriptase inhibitor for the treatment of HIV infection. Sustiva will now be available as a 600 mg tablet to be taken once […]
Barcelona International Conference, July 7-12 Web sites to watch John S. James The XIV International AIDS Conference will take place July 7-12 in Barcelona, Spain — with important satellite meetings starting several days before. These meetings happen only once every two years; no breakthroughs are expected, but important research and medical developments will be […]
Special Issue: Treatment and Survival – new information This issue of AIDS Treatment News brings together some of the most important information on the effect of modern HIV treatment on improved survival. Some cautions: (1) Almost all doctors today agree that not everyone infected with HIV needs to take antiretroviral or other drugs. But everyone […]